Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, ...

As the Distinguished William S. C. Chang Endowed Chair in the UC San Diego Jacobs School of Engineering’s Department of ...

Number of Hedge Fund Holders: 56 Illumina, Inc. (NASDAQ:ILMN) offers sequencing and array based solutions for genetic and ...

Illumina has a long history of driving advancements in genomics, providing the tools and technologies that have ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership ...

As you read this, a white box the size of a refrigerator is hurtling through space at 17,500 miles per hour (28,000 kph), ...

Short-read (Illumina) 16S-EZ - For genus/species identification of bacteria and archaea - Targeted sequencing of 16S rRNA gene (V3 & V4 regions) - Short-read (Illumina) Full Length 16S - For ...

An appeals court ruling that validated its fight against a deal by the gene-sequencing giant Illumina is a boost for the agency’s expansive antitrust strategy. By Andrew Ross Sorkin, ...

2 Since then, aside from the Illumina/Grail transaction, the Commission called in a small number of concentrations. The ...